| Name |
Position |
|---|
| R Aggarwal |
|
| J F Aparicio |
Institute of Biotechnology INBIOTEC, University of León, Spain |
| A Baerga-Ortiz |
Associate Professor, University of Puerto Rico |
| S Bali |
Research Associate, University of Oxford |
| C Barrie |
|
| L Basiliya |
|
| G Berry |
|
| L Betancor |
|
| S S Bethell |
|
| D J Bevitt |
|
| A Bhatt |
Medical Research Council CDA Fellow, Lecturer in Molecular Microbiology, University of Birmingham
|
| C Bisang |
|
| S Boakes |
Associate Director of Microbiology/Deputy Programme Manager at Cantab Biopharmaceuticals Ltd., Luton |
| G A Bohm |
|
| I Bohm |
|
| M Bolle |
|
| A M Bridges |
|
| M J B Brown |
|
| M Bycroft |
|
| P Caffrey |
|
| H Cohen |
|
| H Cooper |
|
| J Cortes |
|
| R J Cox |
|
| A L Cutter (Wilkinson) |
|
| M Deacon |
|
| Y Demydchuk |
Senior Scientist at GlaxoSmithKline plc, London |
| N J Dunster |
|
| Q Fan |
Senior analyst, Credit Suisse
|
| E Frost |
|
| M-J Fernandez Lozano |
Research and Development Scientist-Biochemistry at Phico Therapeutics Ltd., Cambridge |
| S Gaisser |
|
| I S Galloway |
|
| J Garcia-Bernardo |
RNAi HTP screen facility manage, Commissariat a l'energie atomique (CEA) Saclay, Paris
|
| S Garner |
Patent Attorney, Mathys & Squire LLP, London
|
| H Ghoorahoo |
|
| R Goss |
Readership in Biomolecular/Organic Chemistry, University of St Andrews |
| M Gregory |
|
| H Hailes |
Professor of Chemical Biology, University College London |
| S Handa |
|
| U Hanefeld |
Professor of Biocatalysis, Delft University of Technology |
| P Harrison |
|
| M L Heathcote |
GlaxoSmithKline, Stevenage |
| A Hill |
|
| I Hlozbauer |
|
| W Hüttel |
Junior Research Group Leader, University of Freiburg
|
| M Jones |
|
| D Kearney |
|
| G Kearney |
|
| J L Kellenberger |
Chief Scientific Officer, Basilea Pharmaceutica |
| L E Khaw |
|
| F Klein |
|
| A Konig |
|
| D Kwan |
Postdoctoral Fellow, The University of British Columbia
|
| O Lazos |
Analyst, PRMA Consulting, Athens Greece |
| R Lill |
|
| P F Long |
|
| P A S Lowden |
Lecturer in Chemistry, Birkbeck, London |
| H Mamdani |
Computational Chemist, Prometic Biosciences, Cambridge
|
| A Marsden |
|
| A-L Matharu |
|
| A Mingardi |
|
| T Mironenko |
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton
|
| I Molnar |
|
| S Morris |
|
| A Murphy |
|
| Y Noreen-Roddis |
|
| L Ostergaard |
|
| K Pennock |
|
| A Ranganathan |
|
| G A Roberts |
|
| M Roddis |
|
| C J Rowe (Martin) |
|
| A Schneider |
|
| F Schulz |
|
| T Schwecke |
|
| C J Smith |
|
| L Smith |
Investment Analyst, Reed Elsevier Ventures, London |
| D Spiteller |
Emmy Noether Research Group Leader, Max-Planck-Institute for Chemical Ecology |
| C Squire |
|
| Y Sun |
|
| I Thomas |
|
| J Thwaite |
European Patent Attorney, Syngenta |
| M Timoney |
|
| L Tran |
Science Educator, Digital Creative, and Communications Strategist, Weill Cornell Medical College, New York
|
| F Trottman |
|
| O Vergnolle |
Post-Doctoral associate, Albert Einstein College of Medicine, New York
|
| M Wall |
|
| K E Weissman |
Molecular and Structural Enzymology Group, Lorraine University, Vandoeuvre-lès-Nancy, France
|
| J Westcott |
|
| M Wheatcroft |
Research Manager, Avipep, Australia
|
| N Whitehead |
|
| B Wilkinson |
Project Leader, Molecular Microbiology, John Innes Centre
|
| C Wilkinson |
|
| G Wirtz |
|
| M Yurkovick |
|
| P Ziegler (Simic) |
|
